BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28725182)

  • 1. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
    Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
    Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes.
    Richter K; Asci N; Singh VK; Yakoob SH; Meixner M; Zakrzewicz A; Liese J; Hecker A; Wilker S; Stumpf S; Schlüter KD; Rohde M; Gödecke A; Padberg W; Manzini I; Schmalzing G; Grau V
    Front Immunol; 2023; 14():1140592. PubMed ID: 36969210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes.
    Grau V; Richter K; Hone AJ; McIntosh JM
    Front Pharmacol; 2018; 9():1499. PubMed ID: 30687084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and
    Richter K; Papke RL; Stokes C; Roy DC; Espinosa ES; Wolf PMK; Hecker A; Liese J; Singh VK; Padberg W; Schlüter KD; Rohde M; McIntosh JM; Morley BJ; Horenstein NA; Grau V; Simard AR
    Front Cell Neurosci; 2022; 16():779081. PubMed ID: 35431807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphocholine - an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors.
    Richter K; Mathes V; Fronius M; Althaus M; Hecker A; Krasteva-Christ G; Padberg W; Hone AJ; McIntosh JM; Zakrzewicz A; Grau V
    Sci Rep; 2016 Jun; 6():28660. PubMed ID: 27349288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Beta Peptide (Aβ
    Richter K; Ogiemwonyi-Schaefer R; Wilker S; Chaveiro AI; Agné A; Hecker M; Reichert M; Amati AL; Schlüter KD; Manzini I; Schmalzing G; McIntosh JM; Padberg W; Grau V; Hecker A
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32906646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLPI Inhibits ATP-Mediated Maturation of IL-1β in Human Monocytic Leukocytes: A Novel Function of an Old Player.
    Zakrzewicz A; Richter K; Zakrzewicz D; Siebers K; Damm J; Agné A; Hecker A; McIntosh JM; Chamulitrat W; Krasteva-Christ G; Manzini I; Tikkanen R; Padberg W; Janciauskiene S; Grau V
    Front Immunol; 2019; 10():664. PubMed ID: 31019507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation.
    Richter K; Sagawe S; Hecker A; Küllmar M; Askevold I; Damm J; Heldmann S; Pöhlmann M; Ruhrmann S; Sander M; Schlüter KD; Wilker S; König IR; Kummer W; Padberg W; Hone AJ; McIntosh JM; Zakrzewicz AT; Koch C; Grau V
    Front Immunol; 2018; 9():1604. PubMed ID: 30105015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release.
    Hecker A; Küllmar M; Wilker S; Richter K; Zakrzewicz A; Atanasova S; Mathes V; Timm T; Lerner S; Klein J; Kaufmann A; Bauer S; Padberg W; Kummer W; Janciauskiene S; Fronius M; Schweda EK; Lochnit G; Grau V
    J Immunol; 2015 Sep; 195(5):2325-34. PubMed ID: 26202987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphocholine-Modified Lipooligosaccharides of
    Richter K; Koch C; Perniss A; Wolf PM; Schweda EKH; Wichmann S; Wilker S; Magel I; Sander M; McIntosh JM; Padberg W; Grau V
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30096783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice.
    Lykhmus O; Voytenko LP; Lips KS; Bergen I; Krasteva-Christ G; Vetter DE; Kummer W; Skok M
    Front Cell Neurosci; 2017; 11():282. PubMed ID: 28955208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
    Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Nicotinamide Adenine Dinucleotide (β-NAD) Inhibits ATP-Dependent IL-1β Release from Human Monocytic Cells.
    Hiller SD; Heldmann S; Richter K; Jurastow I; Küllmar M; Hecker A; Wilker S; Fuchs-Moll G; Manzini I; Schmalzing G; Kummer W; Padberg W; McIntosh JM; Damm J; Zakrzewicz A; Grau V
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse.
    Smith ML; Souza FG; Bruce KS; Strang CE; Morley BJ; Keyser KT
    Mol Vis; 2014; 20():1328-56. PubMed ID: 25352741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Liu Q; Whiteaker P; Morley BJ; Shi FD; Lukas RJ
    Front Cell Neurosci; 2017; 11():287. PubMed ID: 29018331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors.
    Backhaus S; Zakrzewicz A; Richter K; Damm J; Wilker S; Fuchs-Moll G; Küllmar M; Hecker A; Manzini I; Ruppert C; McIntosh JM; Padberg W; Grau V
    J Lipid Res; 2017 Jun; 58(6):1055-1066. PubMed ID: 28404637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP-Induced Release of IL-1
    Amati AL; Zakrzewicz A; Siebers R; Wilker S; Heldmann S; Zakrzewicz D; Hecker A; McIntosh JM; Padberg W; Grau V
    Mediators Inflamm; 2017; 2017():1434872. PubMed ID: 28757683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic acetylcholine receptors regulate vestibular afferent gain and activation timing.
    Morley BJ; Lysakowski A; Vijayakumar S; Menapace D; Jones TA
    J Comp Neurol; 2017 Apr; 525(5):1216-1233. PubMed ID: 27718229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
    Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
    ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.
    Chernyavsky AI; Arredondo J; Skok M; Grando SA
    Int Immunopharmacol; 2010 Mar; 10(3):308-15. PubMed ID: 20004742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.